CY2026A - Use of 4H-1-benzopyran-4-one derivatives 4H-1-benzopyran-4-one derivatives and medicines containing same - Google Patents
Use of 4H-1-benzopyran-4-one derivatives 4H-1-benzopyran-4-one derivatives and medicines containing sameInfo
- Publication number
- CY2026A CY2026A CY202698A CY202698A CY2026A CY 2026 A CY2026 A CY 2026A CY 202698 A CY202698 A CY 202698A CY 202698 A CY202698 A CY 202698A CY 2026 A CY2026 A CY 2026A
- Authority
- CY
- Cyprus
- Prior art keywords
- benzopyran
- derivatives
- containing same
- medicines containing
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3836676A DE3836676A1 (de) | 1988-10-28 | 1988-10-28 | Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
CY2026A true CY2026A (en) | 1998-02-20 |
Family
ID=6366059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY202698A CY2026A (en) | 1988-10-28 | 1998-02-20 | Use of 4H-1-benzopyran-4-one derivatives 4H-1-benzopyran-4-one derivatives and medicines containing same |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0366061B1 (da) |
JP (1) | JP2879910B2 (da) |
KR (1) | KR100194505B1 (da) |
AT (1) | ATE133170T1 (da) |
AU (1) | AU628409B2 (da) |
CA (1) | CA1336715C (da) |
CY (1) | CY2026A (da) |
DE (2) | DE3836676A1 (da) |
DK (1) | DK175228B1 (da) |
ES (1) | ES2084593T3 (da) |
GR (1) | GR3018739T3 (da) |
HK (1) | HK1006167A1 (da) |
IE (1) | IE69982B1 (da) |
PT (1) | PT92145B (da) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5284856A (en) * | 1988-10-28 | 1994-02-08 | Hoechst Aktiengesellschaft | Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives |
EP0508347A1 (en) * | 1991-04-10 | 1992-10-14 | Hoechst Aktiengesellschaft | 5,7-Dihydroxy-2-methyl-8-[4-(3-hydroxy-1-(1-propyl)) piperidinyl]-4H-1-benzopyran-4-one, its preparation and its use |
US5464871A (en) * | 1993-05-12 | 1995-11-07 | Octamer, Inc. | Aromatic nitro and nitroso compounds and their metabolites useful as anti-viral and anti-tumor agents |
US5733920A (en) * | 1995-10-31 | 1998-03-31 | Mitotix, Inc. | Inhibitors of cyclin dependent kinases |
DE59712561D1 (de) * | 1996-03-12 | 2006-04-13 | Sanofi Aventis Deutschland | Neuartige Prodrugs für die Therapie von Tumoren und entzündlichen Erkrankungen |
DE19802449A1 (de) | 1998-01-23 | 1999-07-29 | Hoechst Marion Roussel De Gmbh | Verfahren zur Herstellung von (-)cis-3-Hydroxy-1-methyl-4-(2,4,6-trimethoxypyhenyl)-piperidin |
DE19959546A1 (de) * | 1999-12-09 | 2001-06-21 | Rhone Poulenc Rorer Gmbh | Pharmazeutische Zubereitung zur Behandlung von Tumorerkrankungen |
US6821990B2 (en) | 2000-01-18 | 2004-11-23 | Aventis Pharma Deutschland Gmbh | Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5, 7-dihydroxy-8 [4R-(3S-hydroxy-1-M ethyl) piperidinyl]-4H-1-benzopyran-4-one |
US6576647B2 (en) | 2000-01-18 | 2003-06-10 | Aventis Pharmaceuticals Inc. | Pseudopolymorph of (—)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4R-(3S-hydroxy -1-methyl)piperidinyl]-4H-1-benzopyran-4-one |
ES2228800T3 (es) * | 2000-01-18 | 2005-04-16 | Aventis Pharmaceuticals Inc. | Solvato de etanol de (-)-cis-2-(2-clorofenil)-5,7-dihidroxi-8-(4r-(3s-hidroxi-1-metil)piperidinil)-4h-1-benzopiran-4-ona. |
FR2805538B1 (fr) * | 2000-02-29 | 2006-08-04 | Hoechst Marion Roussel Inc | Nouveaux derives de flavones, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation |
KR100392468B1 (ko) * | 2000-09-18 | 2003-07-22 | 주식회사 엘지생명과학 | 사이클린 의존 키나아제의 저해제로서 유용한3-히드록시크로멘-4-온 유도체 |
DE10113513A1 (de) * | 2001-03-20 | 2002-10-02 | Medinnova Ges Med Innovationen | Kombinationspräparat zur Prophylaxe und/oder Therapie von Nervenzell- und/oder Gliazellschäden durch ein neues Behandlungsverfahren |
US7547716B2 (en) | 2001-06-08 | 2009-06-16 | Institute Of Medicinal Molecular Design, Inc. | Sulfonamide derivatives |
JP4664597B2 (ja) | 2002-04-17 | 2011-04-06 | サイトキネティクス・インコーポレーテッド | 化合物、組成物および方法 |
TWI331034B (en) * | 2002-07-08 | 2010-10-01 | Piramal Life Sciences Ltd | Inhibitors of cyclin-dependent kinases and their use |
WO2004006865A2 (en) | 2002-07-17 | 2004-01-22 | Cytokinetics, Inc. | Compounds, compositions, and methods |
US20120121692A1 (en) * | 2009-05-08 | 2012-05-17 | Shandong University | Compounds and compositions comprising cdk inhibitors and methods for treating cancer |
EP2580320B1 (en) | 2010-06-14 | 2018-08-01 | The Scripps Research Institute | Reprogramming of cells to a new fate |
WO2012007327A1 (en) | 2010-07-12 | 2012-01-19 | Dkfz Deutsches Krebsforschungszentrum | Wogonin for the prevention and therapy of cardiac hypertrophy |
WO2013113762A1 (en) | 2012-01-31 | 2013-08-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and kits for predicting the risk of having a cutaneous melanoma in a subject |
BR112017022666A8 (pt) | 2015-04-20 | 2022-10-18 | Tolero Pharmaceuticals Inc | Preparando resposta à alvocidib por perfilamento mitocondrial |
TR201911032T4 (tr) | 2015-05-18 | 2019-08-21 | Tolero Pharmaceuticals Inc | Artırılmış biyoyararlanıma sahip alvocıdıb ön ilaçları. |
AU2016301315C1 (en) | 2015-08-03 | 2022-07-07 | Sumitomo Pharma Oncology, Inc. | Combination therapies for treatment of cancer |
WO2018094275A1 (en) | 2016-11-18 | 2018-05-24 | Tolero Pharmaceuticals, Inc. | Alvocidib prodrugs and their use as protein kinase inhibitors |
US11497756B2 (en) | 2017-09-12 | 2022-11-15 | Sumitomo Pharma Oncology, Inc. | Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1 inhibitor alvocidib |
CA3119807A1 (en) | 2018-12-04 | 2020-06-11 | Sumitomo Dainippon Pharma Oncology, Inc. | Cdk9 inhibitors and polymorphs thereof for use as agents for treatment of cancer |
WO2020191326A1 (en) | 2019-03-20 | 2020-09-24 | Sumitomo Dainippon Pharma Oncology, Inc. | Treatment of acute myeloid leukemia (aml) with venetoclax failure |
CN110028475B (zh) * | 2019-05-13 | 2022-07-01 | 中国药科大学 | 基于苯并吡喃结构的新型cdk9抑制剂、其制备方法及应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3329186A1 (de) * | 1983-08-12 | 1985-02-21 | Hoechst Ag, 6230 Frankfurt | Chromonalkaloid, verfahren zu seiner isolierung aus dysoxylum binectariferum, und seine verwendung als arzneimittel |
IN164232B (da) * | 1986-04-11 | 1989-02-04 | Hoechst India |
-
1988
- 1988-10-28 DE DE3836676A patent/DE3836676A1/de not_active Withdrawn
-
1989
- 1989-09-29 CA CA000614537A patent/CA1336715C/en not_active Expired - Lifetime
- 1989-10-24 AT AT89119710T patent/ATE133170T1/de not_active IP Right Cessation
- 1989-10-24 EP EP89119710A patent/EP0366061B1/de not_active Expired - Lifetime
- 1989-10-24 ES ES89119710T patent/ES2084593T3/es not_active Expired - Lifetime
- 1989-10-24 DE DE58909573T patent/DE58909573D1/de not_active Expired - Lifetime
- 1989-10-27 AU AU43841/89A patent/AU628409B2/en not_active Expired
- 1989-10-27 JP JP1278756A patent/JP2879910B2/ja not_active Expired - Lifetime
- 1989-10-27 IE IE348189A patent/IE69982B1/en not_active IP Right Cessation
- 1989-10-27 PT PT92145A patent/PT92145B/pt not_active IP Right Cessation
- 1989-10-27 KR KR1019890015509A patent/KR100194505B1/ko not_active IP Right Cessation
- 1989-10-27 DK DK198905372A patent/DK175228B1/da not_active IP Right Cessation
-
1996
- 1996-01-19 GR GR960400124T patent/GR3018739T3/el unknown
-
1998
- 1998-02-20 CY CY202698A patent/CY2026A/xx unknown
- 1998-06-12 HK HK98105251A patent/HK1006167A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2084593T3 (es) | 1996-05-16 |
IE69982B1 (en) | 1996-10-16 |
DK537289D0 (da) | 1989-10-27 |
DE3836676A1 (de) | 1990-05-03 |
AU4384189A (en) | 1990-05-03 |
PT92145A (pt) | 1990-04-30 |
KR900006325A (ko) | 1990-05-07 |
HK1006167A1 (en) | 1999-02-12 |
PT92145B (pt) | 1995-06-30 |
ATE133170T1 (de) | 1996-02-15 |
JP2879910B2 (ja) | 1999-04-05 |
DK175228B1 (da) | 2004-07-19 |
IE893481L (en) | 1990-04-28 |
AU628409B2 (en) | 1992-09-17 |
DK537289A (da) | 1990-04-29 |
KR100194505B1 (ko) | 1999-06-15 |
GR3018739T3 (en) | 1996-04-30 |
CA1336715C (en) | 1995-08-15 |
EP0366061B1 (de) | 1996-01-17 |
DE58909573D1 (de) | 1996-02-29 |
JPH02178225A (ja) | 1990-07-11 |
EP0366061A1 (de) | 1990-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1006167A1 (en) | Use of 4h-1-benzopyran-4-one derivatives 4h-1-benzopyran-4-one derivatives and medicines containing same | |
AU1608692A (en) | Amidinophenylalanine derivatives, a process for the preparation thereof, use thereof and agents containing these as anticoagulants | |
IL86456A (en) | Tetrazole derivatives useful as intermediates for preparing antihypertensive compounds | |
ZA925128B (en) | Pyrrolidine derivatives,their preparation and medicaments containing them | |
AU4419193A (en) | Synthesis of 1,4,7-triazacyclononane derivatives | |
IL89691A0 (en) | Pharmaceutical compositions containing bis(3,4-dihydro-2h-1-benzopyran)derivatives for lowering blood pressure,certain such novel compounds and their preparation | |
DK0553890T3 (da) | Diphenylheteroalkylderivater, deres fremstilling og lægemidler og kosmetisk fremstillet derudfra | |
ES2010114A6 (es) | Procedimiento de preparacion de derivados de los acidos 1,4-dihidro-4-oxoquinolein-3-carboxilicos. | |
EP0530505A3 (en) | Hydantoin derivatives | |
HU9201288D0 (en) | Kinoxalyne derivatives, process for their production and medical preparations containing them | |
IL98262A0 (en) | Chromone derivatives and pharmaceutical compositions containing them | |
ES2086065T3 (es) | Preparacion de tetrahidropiridinas sustituidas. | |
NZ248794A (en) | 3-carboxy-(and phosphonoxy-)alkatriene-substituted chromene derivatives and medicaments | |
ZA932359B (en) | 3-Aminochroman spiro compounds processes for preparing them and pharmaceutical compositions containing them | |
HU892601D0 (en) | Process for producing substituted or non-substituted 4(5)-(-amino-alkyl)-imidazole derivatives as well as pharmaceutical preparatives containing these compounds | |
NO903291D0 (no) | Renin-hemmende aminooligohydroksy-derivater. | |
GR3025290T3 (en) | Novel 2h-benzo b)pyrane derivatives substituted in the 4 position by aryl or n-heteroaryl, process for producing them and preparations containing the compounds | |
HUT54682A (en) | Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds | |
GB2055366B (en) | 2-phenylimino-5-(2'-carboxyphenyl)-1,3,4-thiadiazol-4-ine derivatives useful as plant-growth regulating agents | |
ZA924888B (en) | Process for the synthesis of enantiomers of 3-aminochroman compounds | |
ATE119394T1 (de) | Verwendung von myricetin-3-0-beta-d-glucuronid als arzneimittel. | |
ZA917001B (en) | Medicaments containing substituted 2-cyclohexene derivates and their use for the control of diseases | |
ZA874878B (en) | Pyran derivatives |